| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/08/2004 | US20040006031 For therapy of disease or condition such as cholesterol metabolism, cardiovascular disease, atherosclerosis, angiogenesis |
| 01/08/2004 | US20040006030 For therapy of hyperproliferative disorder, hyperactivation of an immune response, neurodegenerative disorder |
| 01/08/2004 | US20040006029 Antisense modulation of cell division cycle 2 expression |
| 01/08/2004 | US20040005707 Antisense modulation of integrin beta 5 expression |
| 01/08/2004 | US20040005706 Antisense modulation of DEXRAS1 expression |
| 01/08/2004 | US20040005705 Comprises oligonucleotides for controlling expression of phospholipase D2 and treating cancer and nervous system disorders; gene expression inhibition; antisense therapy |
| 01/08/2004 | US20040005685 97316, a human amine oxidase family member and uses therefor |
| 01/08/2004 | US20040005678 Introducing into host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate |
| 01/08/2004 | US20040005665 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, tumorous and nervous system disorders |
| 01/08/2004 | US20040005659 Comprises nucleotide sequences coding serine protease (PSS11-L) protein for diagnosing, treating and preventing osteoarthritic and bone disorders; gene therapy; gene expression inhibition; enzyme inhibitors |
| 01/08/2004 | US20040005642 Comprises expression vectors coding antiproliferative agents; antisense agents; tumor diagnosis and treatment |
| 01/08/2004 | US20040005626 Comprises nucleotide sequences coding membrane protein for diagnosing and treating inflammatory and tumor disorders |
| 01/08/2004 | US20040005624 84573, a human protein kinase family member and uses therefor |
| 01/08/2004 | US20040005613 Detecting restriction fragment length polymorphisms associated with allelic mutation using peptide nucleic acids |
| 01/08/2004 | US20040005611 PNA probes, probe sets, methods and kits pertaining to the determination of Listeria |
| 01/08/2004 | US20040005603 Gene shinc-3 and diagnostic and therapeutic uses thereof |
| 01/08/2004 | US20040005602 DNA encoding the vertebrate homolog of hedgehog, Vhh-1, expressed by the notocord, and uses thereof |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005596 Gene amplification in cancer |
| 01/08/2004 | US20040005595 Inversion probes |
| 01/08/2004 | US20040005592 Materials and methods relating to therapy and diagnosis using targeting of cells that express DCAL-Hy polypeptides |
| 01/08/2004 | US20040005579 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005577 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005575 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005571 Axs gene and protein and methods related thereto |
| 01/08/2004 | US20040005570 Oligonucleotides which control expression of geranylgeranyl diphosphate synthase for treating tumors, apoptosis aberrations and developmental disorders; gene expression inhibition; antisense therapy |
| 01/08/2004 | US20040005569 Antisense modulation of NF-kappa-B p50 subunit expression |
| 01/08/2004 | US20040005568 Movement of multi-enzymatic nanoassemblies on recognition landscapes |
| 01/08/2004 | US20040005567 Antisense modulation of cyclin-dependent kinase 4 expression |
| 01/08/2004 | US20040005565 Antisense modulation of livin expression |
| 01/08/2004 | US20040005559 Markers of neuronal differentiation and morphogenesis |
| 01/08/2004 | US20040005555 Molecular diagnosis of bactermia |
| 01/08/2004 | US20040005553 Comprises membrane protein for treating cancer, inflammation and autoimmune disorders |
| 01/08/2004 | US20040005543 Compositions and methods for binding agglomeration proteins |
| 01/08/2004 | US20040005542 Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes |
| 01/08/2004 | US20040005353 Delivery system for antisense oligonucleotides involves a liposomal composition, comprising a liposome which consists essentially of neutral phospholipids and an antisense oligonucleotide that is entrapped in the liposome and is |
| 01/08/2004 | US20040005333 Recombinant gene fusion encoding a human IgG1 heavy chain constant region and a single-chain variable fragment antibody of 1A4A1 monoclonal antibody is disclosed. The recombinant antibody of the present invention confers human immune |
| 01/08/2004 | US20040005328 Novel antigens of B. catarrhalis are provided, together with their use in vaccines as well as methods of diagnosing and/or detection. Branhamella catarrhalis (also known as Moraxella catarrhalis) is a gram-negative aerobic bacterium that causes |
| 01/08/2004 | DE10227814A1 Verfahren zur Abspaltung von labilen funtionellen Gruppen aus chemischen Verbindungen Method for the removal of labile funtionellen groups of chemical compounds |
| 01/08/2004 | CA2491395A1 Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490290A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | CA2490283A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1378572A1 Bmp-11 compositions |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378569A1 Method of extracting virus gene and extraction apparatus |
| 01/07/2004 | EP1377305A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/07/2004 | EP1377304A2 A novel trp2 isoform containing hla-a2 restricted cytotoxic t lymphocyte epitopes |
| 01/07/2004 | EP1028741B1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1465716A Determination for specificity of one segmentum gonococcus DNA sequence (3) and use thereof |
| 01/07/2004 | CN1465715A Determination for specificity of one segmentum gonococcus DNA sequence (5) and use thereof |
| 01/07/2004 | CN1465714A One segmentum gonococcus DNA sequence (2) specificity detemination and use thereof |
| 01/07/2004 | CN1465713A Determination for specificity of ureaplasma DNA sequence (1) and use thereof |
| 01/07/2004 | CN1465708A Determination for specificity of candida albicans DNA sequence (3) and use thereof |
| 01/07/2004 | CN1465707A Determination for specificity of Candida albicans DNA sequence (2) and use thereof |
| 01/07/2004 | CN1465706A Determination for specificity of Candida albicans DNA sequence (5) and use thereof |
| 01/07/2004 | CN1465705A Determination for specificity of Candida albicans DNA sequence (4) and use thereof |
| 01/07/2004 | CN1465699A Gene engineering of producing fructose by inulase hydrolyzing helianthus tuberosus |
| 01/07/2004 | CN1465696A Polypeptide-trorsine 14 and polynucleotide for coding said polypeptide |
| 01/07/2004 | CN1465587A Polypeptide-chondriosome carrier 18 and polynucleotide for colding said polypeptide |
| 01/07/2004 | CN1465584A SiRNA target sequence bank of SARS virus and use thereof |
| 01/07/2004 | CN1133650C A method of identifying CFTP-binding compounds useful for activating chloride conductance in animal cells |
| 01/06/2004 | US6673940 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
| 01/06/2004 | US6673912 2′-O-aminoethyloxyethyl-modified oligonucleotides |
| 01/06/2004 | US6673908 Nucleic acid mutant with nucleotide sequence replacements; antiinflammatory agents |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673779 Promoting mucociliary or cough clearance of retained mucus secretions from the lungs, sinuses, upper airways, ears, eyes, genitourinary tract, spermatozoa, ovaries, fallopian tubes, neutrophils, and macrophages |
| 01/06/2004 | US6673616 Cleavage of nucleic acid with hairpin motif using exo- or endonucleases; detection of bacterial or viral pathogens |
| 01/06/2004 | US6673601 Plasmid; expression vector encodes glycoprotein |
| 01/06/2004 | US6673550 Probes for use in the detection and measurement of preferential compound in sample |
| 01/06/2004 | US6673548 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/06/2004 | US6673544 Method for the light-controlled synthesis of biochips |
| 01/06/2004 | US6673344 Antibodies to human CKβ-10/MCP-4 |
| 01/02/2004 | EP1375677A1 Probes for detecting and identifying helicobacter pylori |
| 01/02/2004 | EP1373562A2 Method for determining whether a test compound binds to a large rna target |
| 01/02/2004 | EP1373520A2 Motor proteins and methods for their use |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373487A2 Regulation of human protein kinase-like protein |
| 01/02/2004 | EP1373296A2 Proteins producing an altered immunogenic response and methods of making and using the same |
| 01/02/2004 | EP1373286A2 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid support |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1185698A4 Automated nucleic acid compaction device |
| 01/02/2004 | EP0719343B1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 01/01/2004 | US20040003439 Novel grass cultivar named 'Benest 1' and 'Dongrae Koryogi'-specific STS marker |
| 01/01/2004 | US20040003428 A polynucleotide having a nucleotide sequence encoding amino acid sequence from methionine at position 1 to serine at position 361 of preferred amino acid or sequence having one or more amino acid deletion, insertion or substitution |
| 01/01/2004 | US20040003422 An expression cassette containing the proopiomelanocortin (POMC) enhancer, and a nucleic acid sequence encoding POMC contains at least one exon, wherein a polylinker having an unique site for restriction enzyme is inserted into the exon; gene regulates weight and fat mass |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040002595 Nucleic acid labeling compounds |
| 01/01/2004 | US20040002594 Removal of extraneous substances from biological fluids containing nucleic acids and the recovery of nucleic acids |
| 01/01/2004 | US20040002593 PAAD - (pyrin, AIM (absent in melanoma), ASC ( apoptosis -associated speck-like protein containing a capsase-recruitment domain -CARD)); identifying agents that modulate PAAD domain-mediated inhibition of NF kappa B activity |
| 01/01/2004 | US20040002591 50 human secreted proteins |
| 01/01/2004 | US20040002467 Antisense modulation of ADAM12 expression |
| 01/01/2004 | US20040002465 Fungicides, parasiticides, antiprotozoa agents; binding antibiotic to nucleic acid |
| 01/01/2004 | US20040002154 Methods for preparing libraries of unique tags and related screening methods |
| 01/01/2004 | US20040002136 Mutant Chrysosporium strain comprising a nucleic acid sequence encoding a polypeptide; expressing and secreting heterologous proteins |
| 01/01/2004 | US20040002109 Process for identifying modulators of G-protein-coupled receptors |
| 01/01/2004 | US20040002074 Compositions and methods for the determination of the presence of specific microorganisms in a sample using the amplification of DNA; provide an internal standard for the validation of the amplification of DNA |